| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mostafa Bondok, Anne Xuan-Lan Nguyen, Leonardo Lando, Albert Y W. Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review. Clinical ophthalmology (Auckland, N.Z.). vol 18. 2024-12-04. PMID:39629058. |
adverse ocular impact and emerging therapeutic potential of cannabis and cannabinoids: a narrative review. |
2024-12-04 |
2024-12-06 |
Not clear |
| Mostafa Bondok, Anne Xuan-Lan Nguyen, Leonardo Lando, Albert Y W. Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review. Clinical ophthalmology (Auckland, N.Z.). vol 18. 2024-12-04. PMID:39629058. |
this narrative review aims to explore the adverse effects and therapeutic applications of cannabis and cannabinoids on the eye, given its growing clinical and non-clinical uses. |
2024-12-04 |
2024-12-06 |
Not clear |
| Mostafa Bondok, Anne Xuan-Lan Nguyen, Leonardo Lando, Albert Y W. Adverse Ocular Impact and Emerging Therapeutic Potential of Cannabis and Cannabinoids: A Narrative Review. Clinical ophthalmology (Auckland, N.Z.). vol 18. 2024-12-04. PMID:39629058. |
the current literature reports several adverse ocular effects of cannabis and cannabinoids, including eyelid tremor, ptosis, reduced corneal endothelial cell density, dry eyes, red eyes, and neuro-retinal dysfunction. |
2024-12-04 |
2024-12-06 |
Not clear |
| Nadja Walle, Christiane Dings, Omar Zaher, Adrian A Doerr, Benjamin Peters, Matthias W Laschke, Thorsten Lehr, Michael D Menger, Peter H Schmidt, Markus R Meyer, Nadine Schaefe. Does a carboxamide moiety alter the toxicokinetics of synthetic cannabinoids? A study after pulmonary and intravenous administration of cumyl-5F-P7AICA to pigs. Archives of toxicology. 2024-12-04. PMID:39630204. |
synthetic cannabinoids (scs) are consumed as an alternative to cannabis. |
2024-12-04 |
2024-12-06 |
Not clear |
| Arsalan Rauf, Mudassar Nisar, Muhammad Shaeel, Ali Athar, Muhammad Mujtaba Ur Rehman, Filzah Fahee. The Potential of Cannabis in Managing Inflammatory Bowel Disease and Its Future Perspective. Cureus. vol 16. issue 10. 2024-12-03. PMID:39624503. |
there is a need for large randomized placebo-controlled trials using standardized compositions of cannabinoids with long-term follow-up as cannabis is now an emerging drug to be used for ibd. |
2024-12-03 |
2024-12-06 |
Not clear |
| P Thiebot, R Magny, P Martins, P Houze, V Bloch, F Vorspan, N Auzeil, L Laba. Quantitative analysis of cannabinoids and metabolites in oral fluid by volumetric absorptive microsampling combined with UHPLC-HRMS. Analytical and bioanalytical chemistry. 2024-12-03. PMID:39625516. |
we present here a fully optimized quantitative method for seven cannabinoids, including four metabolites, in oral fluid, Δ9-tetrahydrocannabinol, 11-hydroxy-Δ9-tetrahydrocannabinol and 11-nor-9-carboxy-Δ9-tetrahydrocannabinol; cannabidiol, 7-hydroxy and 7-carboxycannabidiol; and cannabinol. |
2024-12-03 |
2024-12-06 |
Not clear |
| Quincy Chopra, Vincent Peyko, Jessica Annie Lee, Leo Puhalla, David J Gemmel, Todd Boloti. Droperidol Plus Diphenhydramine for Symptom Improvement in Suspected Cannabinoid Hyperemesis Syndrome: A Prospective Cohort Study. Open access emergency medicine : OAEM. vol 16. 2024-12-02. PMID:39619486. |
cannabinoid hyperemesis syndrome (chs) is characterized by recurrent, paroxysmal episodes of nausea, vomiting, and abdominal discomfort in chronic cannabis users. |
2024-12-02 |
2024-12-06 |
Not clear |
| Michele Santoni, Marco Pisti. Maternal Immune Activation and Endocannabinoid System: Focus on Two-Hit Models of Schizophrenia. Biological psychiatry. 2024-12-01. PMID:39617194. |
a growing body of research focuses on the interaction between mia and cannabis use during adolescence, considering the role of the endocannabinoid system in neurodevelopment and in neurodevelopmental disorders. |
2024-12-01 |
2024-12-06 |
Not clear |
| Elena Ahrens, Luca J Wachtendorf, Kevin P Hill, Maximilian S Schaefe. Considerations for Anesthesia in Older Adults with Cannabis Use. Drugs & aging. 2024-12-01. PMID:39617807. |
in addition to habitual cannabis use, recommendations for treatment of chronic pain with cannabinoids have become increasingly more common. |
2024-12-01 |
2024-12-06 |
Not clear |
| Vajja Krishna Rao, Melissa M Lewis-Bakker, Ewa Wasilewski, Hance A Clarke, Lakshmi P Kotr. Stereoisomers of cannabidiols and their pharmacological activities - A potentially novel direction for cannabinoids. Bioorganic & medicinal chemistry. vol 117. 2024-11-29. PMID:39612769. |
cannabidiol (cbd), a bicyclic non-psychoactive cannabinoid biosynthesized by cannabis spp. |
2024-11-29 |
2024-12-02 |
Not clear |
| Isobel Lavender, Grace Garden, Ronald R Grunstein, Brendon J Yee, Camilla M Hoyo. Using Cannabis and CBD to Sleep: An Updated Review. Current psychiatry reports. 2024-11-29. PMID:39612156. |
cannabis sativa and constituent cannabinoids are in widespread use for the treatment of sleep disorders where many patients desire pharmacotherapy. |
2024-11-29 |
2024-12-01 |
Not clear |
| Han-Ting Chen, Ken Macki. CB1 and CB2 receptors differentially modulate the cognitive impact of maternal immune activation and perinatal cannabinoid exposure bioRxiv : the preprint server for biology. 2024-11-28. PMID:39605459. |
similarly, cannabis use and exposure of the fetus to cannabinoids during pregnancy (pce) may elicit neuroinflammation and lead to detrimental behavioral outcomes. |
2024-11-28 |
2024-11-30 |
mouse |
| Rayssa Ribeiro, Yasmin Cunha da Silva, Ricardo Finotti, Gabriel Reis Alves Carneiro, Gustavo Ramalho Cardoso Dos Santos, Henrique Marcelo Gualberto Pereira, Monica Costa Padilha, Valdir F Veiga-Junio. Trema micranthum (L.) Blume as a new source of cannabinoids. Scientific reports. vol 14. issue 1. 2024-11-28. PMID:39609538. |
trema micranthum (cannabaceae) has emerged as a promising new source of cannabinoids, including cannabidiol (cbd). |
2024-11-28 |
2024-12-01 |
Not clear |
| Rayssa Ribeiro, Yasmin Cunha da Silva, Ricardo Finotti, Gabriel Reis Alves Carneiro, Gustavo Ramalho Cardoso Dos Santos, Henrique Marcelo Gualberto Pereira, Monica Costa Padilha, Valdir F Veiga-Junio. Trema micranthum (L.) Blume as a new source of cannabinoids. Scientific reports. vol 14. issue 1. 2024-11-28. PMID:39609538. |
given the substantial medicinal demand for cannabinoids and the regulatory challenges associated with cannabis sativa due to the presence of Δ |
2024-11-28 |
2024-12-01 |
Not clear |
| Kristina K Gagalova, Yifan Yan, Shumin Wang, Till Matzat, Simone D Castellarin, Inanc Birol, David Edwards, Mathias Schuet. Leaf pigmentation in Plant direct. vol 8. issue 11. 2024-11-27. PMID:39600728. |
leaf pigmentation in cannabis plants produce a spectrum of secondary metabolites, encompassing cannabinoids and more than 300 non-cannabinoid compounds. |
2024-11-27 |
2024-11-29 |
Not clear |
| Meagan Sheldon, Michael Ammons, Kenneth Nugen. Acute Toxicity With Lactic Acidosis Associated With Cannabinoid Gummies. Cureus. vol 16. issue 10. 2024-11-27. PMID:39600759. |
the use of marijuana and cannabinoids is widespread throughout the united states, and these drugs can cause both acute and chronic medical disorders. |
2024-11-27 |
2024-11-29 |
Not clear |
| Meagan Sheldon, Michael Ammons, Kenneth Nugen. Acute Toxicity With Lactic Acidosis Associated With Cannabinoid Gummies. Cureus. vol 16. issue 10. 2024-11-27. PMID:39600759. |
the patient described in this case report ingested a large number of edible cannabinoid gummies. he developed a sequence of toxic states that included lethargy, agitation, vomiting, tachycardia, hypertension, acute respiratory failure, and elevated lactic acid levels. these clinical syndromes resolved over the next 24 hours with supportive intensive care unit management. the medical literature indicates that cannabis toxicity can cause acute lactic acidosis in some patients. this possibility needs to be considered when patients present to the emergency room with hypertension, tachycardia, and lactic acidosis. |
2024-11-27 |
2024-11-29 |
Not clear |
| Mohsen Yoosefzadeh Najafabadi, Davoud Torkamane. Machine learning-enhanced multi-trait genomic prediction for optimizing cannabinoid profiles in cannabis. The Plant journal : for cell and molecular biology. 2024-11-27. PMID:39602132. |
machine learning-enhanced multi-trait genomic prediction for optimizing cannabinoid profiles in cannabis. |
2024-11-27 |
2024-11-29 |
Not clear |
| Mohsen Yoosefzadeh Najafabadi, Davoud Torkamane. Machine learning-enhanced multi-trait genomic prediction for optimizing cannabinoid profiles in cannabis. The Plant journal : for cell and molecular biology. 2024-11-27. PMID:39602132. |
this pioneering study implements gs and ml to optimize cannabinoid profiles in cannabis breeding. |
2024-11-27 |
2024-11-29 |
Not clear |
| Mohsen Yoosefzadeh Najafabadi, Davoud Torkamane. Machine learning-enhanced multi-trait genomic prediction for optimizing cannabinoid profiles in cannabis. The Plant journal : for cell and molecular biology. 2024-11-27. PMID:39602132. |
we analyzed a representative population of drug-type cannabis accessions, quantifying major cannabinoids and utilizing high-density genotyping with 250k snps for gs. |
2024-11-27 |
2024-11-29 |
Not clear |